Search results
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 2 hours agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 7 days agoWith her days numbered, the courageous patient decided together with her treating physicians to try...
Barrio Cafe was Chef Silvana's 'throne of power.' These Phoenix chefs carry her legacy
AZCentral | The Arizona Republic via Yahoo News· 5 hours agoOlivares of Lola's Tacos: 'She made me feel seen' Lola Olivares, the owner of Lola's Tacos, was one...
Lung Scarring: What to Know
Verywell Health via Yahoo News· 6 days agoIt’s more common in people who had severe COVID infection, as well as in males and older people. Autoimmune diseases Autoimmune ...
In Treating IBD, Consider Diet and Dentistry
Medscape· 12 hours agoDr David Johnson highlights five compelling studies from this year's Digestive Disease Week exploring the role of oral health, diet, and intestinal...
Teasing apart sex differences in heart disease
The State· 9 hours agoDamian Di Florio, Ph.D., remembers the lightning-bolt moment five years ago when he began thinking differently about the questions scientists ask. "That was the first alarm bell for me," says ...
MS Med Nearly Eliminates Disease Activity on MRI
Medscape· 12 hours agoA second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...
Type 1 Diabetes Group Grows Up: JDRF Now 'Breakthrough T1D'
Medscape· 2 days agoThe type 1 diabetes (T1D) research and advocacy organization Juvenile Diabetes Research Foundation...
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical...
Forrest City Times-Herald· 2 days agoVGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, has entered into ...
Teprotumumab Gives Lasting Relief from Thyroid Eye Disease
Medscape· 4 days agoNearly 2 years after their final teprotumumab transfusion, 82% of patients didn't need further...
